All In Biotech

Drug Trial Radar · NCT03626688

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH

Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 687 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

687

Actual

Start

Jan 24, 2019

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Aug 13, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.

Conditions

  • PAH
  • Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Hypertension
  • Connective Tissue Diseases
  • Familial Primary Pulmonary Hypertension
  • Vascular Diseases
  • Cardiovascular Diseases
  • Hypertension, Pulmonary
  • Lung Diseases
  • Respiratory Tract Disease

Interventions

  • RalinepagDrug

    Active

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from randomization to the first adjudicated protocol-defined clinical worsening eventTime frame: The study duration was event-based. This parameter was assessed from randomization until the conclusion of the study, up to 3 years

Locations

209 sites in 33 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • St. Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • University of Arizona

    Tucson, Arizona

  • UCSD Health Sciences

    La Jolla, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Keck Hospital of USC

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • VA Greater Los Angeles Healthcare System

    Los Angeles, California

  • University of California, Irvine

    Orange, California

  • University of California Davis Medical Center

    Sacramento, California

  • SBPA Research LLC

    Santa Barbara, California

  • Stanford Healthcare

    Stanford, California

  • LA Biomedical Research Institute Harbor-UCLA Medical Center

    Torrance, California

  • University of Colorado Hospital

    Aurora, Colorado

  • National Jewish Health

    Denver, Colorado

  • University of Florida

    Gainesville, Florida

  • University of Miami

    Miami, Florida

  • Central Florida Pulmonary Group

    Orlando, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Emory University Hospital

    Atlanta, Georgia

  • Piedmont Healthcare Pulmonary and Critical Care Research

    Austell, Georgia

  • University of Chicago Medical Center

    Chicago, Illinois

  • Ascension Alexian Brothers

    Elk Grove Village, Illinois

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Community Health Network Cancer Center North

    Indianapolis, Indiana

  • St. Vincent Medical Group, Inc.

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Kentuckiana Pulmonary Research Center

    Louisville, Kentucky

  • Ochsner Medical Center

    New Orleans, Louisiana

  • Chest Medicine Associates

    South Portland, Maine

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Boston University Medical Center

    Boston, Massachusetts

  • Spectrum Health Medical Group

    Grand Rapids, Michigan

  • Washington University School of Medicine

    St Louis, Missouri

  • Nebraska Medical Center

    Omaha, Nebraska

  • University of New Mexico

    Albuquerque, New Mexico

Showing 40 of 209 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.